Cervical malignancy refers to cancerous tumors that develop in the cervix, which is the lower part of the uterus that connects to the vagina. The majority of cervical cancers are caused by persistent infections with high-risk types of human papillomavirus (HPV).
Regular cervical cancer screening, including Pap tests and HPV testing, can help detect precancerous changes or early-stage cervical cancer before symptoms develop. Treatment options for cervical malignancy depend on the stage of cancer and may include surgery, radiation therapy, chemotherapy, or a combination of these approaches. Vaccination against high-risk HPV types and practicing safe sexual behaviors, such as using condoms, can reduce the risk of HPV infection and the development of cervical malignancy. Early detection and timely treatment significantly improve the prognosis and outcomes for women with cervical cancer.
Pathogenesis features:
Clinical features: